PVLA — PALVELLA THERAPEUTICS INC NE

Ownership history in Frazier Life Sciences Management, L.P.  ·  5 quarters on record

This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in PALVELLA THERAPEUTICS INC NE (PVLA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.03% (2025 Q4)
Avg. % of fund
1.05%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 722,400 — 0% 2.03% $75.6M $104.67
2025 Q3 UNCHANGED 722,400 — 0% 1.36% $45.3M $62.69
2025 Q2 ADDED 722,400 +32,388 +4.7% 0.65% $16.3M $22.54
2025 Q1 ADDED 690,012 +36,120 +5.5% 0.88% $19.3M $27.99
2024 Q4 INITIATED 653,892 — — 0.33% $7.8M $12.00
% of Fund (quarterly)    PVLA price (monthly, adj. close)

Other funds also holding PVLA

As of 2025 Q4 — sorted by position size

Clio Asset Management LLC 7.45% First Light Asset Management, LLC 3Y 7Y 5.67% BVF INC/IL 3Y 7Y 3.1% MPM BioImpact LLC 3Y 2.46% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.91% SUPERSTRING CAPITAL MANAGEMENT LP 1.43% Samsara BioCapital, LLC 3Y 7Y 1.13% Lisanti Capital Growth, LLC 3Y 7Y 1.03% Artia Global Partners LP 3Y 0.88% SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3Y 7Y 0.85%
← Back to Frazier Life Sciences Management, L.P. Holdings